Klaus R Trott
Overview
Explore the profile of Klaus R Trott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Wondergem J, Boerma M, Kodama K, Stewart F, Trott K
Radiat Environ Biophys
. 2013 Sep;
52(4):425-34.
PMID: 23999657
The authors of this report met at the Head Quarter of the International Atomic Energy Agency (IAEA) in Vienna, Austria, on 2-4 July 2012, for intensive discussions of an abundance...
3.
Orecchia R, Jereczek-Fossa B, Rondi E, Bossi-Zanetti I, Meaglia I, Luraschi R, et al.
Tumori
. 2013 Feb;
98(6):715-21.
PMID: 23389357
Aims And Background: To calculate peripheral radiation dose to the second primary site in patients who have developed a second malignancy after breast cancer radiotherapy (index cases) and to compare...
4.
Ottolenghi A, Smyth V, Trott K
Radiat Prot Dosimetry
. 2011 Jan;
143(2-4):533-5.
PMID: 21199824
As radical radiotherapy treatments become more effective, more and more cancer patients are becoming cured of their disease and surviving for decades. Damage to exposed healthy tissues that becomes manifest...
5.
Darby S, Cutter D, Boerma M, Constine L, Fajardo L, Kodama K, et al.
Int J Radiat Oncol Biol Phys
. 2010 Feb;
76(3):656-65.
PMID: 20159360
No abstract available.
6.
Fidarova E, El-Emir E, Boxer G, Qureshi U, Dearling J, Robson M, et al.
Clin Cancer Res
. 2008 May;
14(9):2639-46.
PMID: 18451227
Purpose: Most radioimmunotherapy studies on radiolabeled antibody distribution are based on autoradiographic and radioluminographic data, which provide a lack of detailed information due to low resolution. We used fluorescently labeled...
7.
Hendry J, Akahoshi M, Wang L, Lipshultz S, Stewart F, Trott K
Radiat Environ Biophys
. 2008 Jan;
47(2):189-93.
PMID: 18193445
No abstract available.
8.
Bentzen S, Atasoy B, Daley F, Dische S, Richman P, Saunders M, et al.
J Clin Oncol
. 2005 Aug;
23(24):5560-7.
PMID: 16110017
Purpose: Accelerated repopulation is a main reason for locoregional failure after fractionated radiotherapy for head and neck squamous cell carcinoma (HNSCC). Epidermal growth factor receptor (EGFR) is a key controller...
9.
Klymenko S, Bink K, Trott K, Bebeshko V, Bazyka D, Dmytrenko I, et al.
Exp Oncol
. 2005 Apr;
27(1):71-5.
PMID: 15812362
Aim: Although acute myelogenous leukemia (AML) arising after radiation exposure is considered to be secondary, little is known about the molecular mechanisms by which the radiation induces the leukemogenic phenotype....
10.
Takahashi T, Schoemaker M, Trott K, Simon S, Fujimori K, Nakashima N, et al.
J Epidemiol
. 2003 Apr;
13(2):99-107.
PMID: 12675119
The US nuclear weapons testing program in the Pacific conducted between 1946 and 1958 resulted in radiation exposure in the Marshall Islands. The potentially widespread radiation exposure from radio-iodines of...